FLT1 and COVID-19: The findings suggest that the activation of the VEGF/VEGFR-1 pathway may play an essential role in the angiogenic process in COVID-19 patients, contributing to the development of new vessels in the areas of hypoxia, inflammation and viral replication, which in turn contributes to the increase in vascular hypertrophy observed in this study.